ASHLEY MULLICAN: Open Payments
NPI 1013426675 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,433 in 148 payments from 21 companies in 2025. Trend: 2023 $2,883 · 2024 $2,620 · 2025 $2,433
Food & beverage: $2,433
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $328 |
| AstraZeneca Pharmaceuticals LP | 16 | $291 |
| Bausch Health US, LLC | 13 | $289 |
| Amgen Inc. | 14 | $253 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $221 |
| ABBVIE INC. | 24 | $211 |
| Axsome Therapeutics, Inc. | 3 | $157 |
| Tris Pharma Inc | 8 | $140 |
| Corium, LLC | 3 | $80 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $68 |
Products named: APLENZIN, CAPLYTA, Wegovy, EVENITY, AIRSUPRA, Auvelity, Dyanavel XR, Ozempic.
Industry payments across GA — which companies pay providers there.
